Changes in ultrasonographic appearance of adrenal glands in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane

Veterinary Radiology and Ultrasound

Volumn 44, Issue 6, 2003, Pages 682-685

  Mantis, Panagiotis ^a   Lamb, Christopher R ^b   Witt, Angela L ^b   Neiger, Reto ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b NONE

Author keywords

Adrenal glands; Dog; Hyperadrenocorticism; Ultrasonography

Indexed keywords

TRILOSTANE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROSTANOLONE; DRUG DERIVATIVE; ENZYME INHIBITOR;

ADRENAL GLAND; ADRENAL GLAND EXAMINATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; HYDROCORTISONE RELEASE; HYPERADRENOCORTICISM; HYPOPHYSIS; NEGATIVE FEEDBACK; NONHUMAN; ADRENAL CORTEX HYPERFUNCTION; ANIMAL; ANIMAL DISEASE; DOG; DOG DISEASE; DRUG ANTAGONISM; DRUG EFFECT; EVALUATION; FEMALE; MALE; ORAL DRUG ADMINISTRATION; PATHOLOGY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

3-HYDROXYSTEROID DEHYDROGENASES; ADMINISTRATION, ORAL; ADRENAL GLANDS; ADRENOCORTICAL HYPERFUNCTION; ANIMALS; DIHYDROTESTOSTERONE; DOG DISEASES; DOGS; ENZYME INHIBITORS; FEMALE; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 1342290253     PISSN: 10588183     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2003.tb00531.x     Document Type: Article

References (23)

1. Feldman EC, Nelson RW. Canine and feline endocrinology and reproduction. 2nd ed. Philadelphia: WB Saunders; 1996, pp 187-265.
2. den Hertog E, Braakman JC, Teske E, Kooistra HS, Rijnberk A. Results of non-selective adrenocorticolysis by o,p′-DDD in 129 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 1999;144:12-17.
3. Peterson ME, Kintzer PP. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs. Semin Vet Med Surg (Small Anim) 1994;9:127-131.
4. Rijnberk A, Belshaw BE. An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism. Vet Rec 1988;122:486-488.
5. Kintzer PP, Peterson ME. Mitotane (o,p′-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1991;5:182-190.
6. Bruyette DS, Ruehl WW, Entriken T, Griffin D, Darling L. Management of canine pituitary-dependent hyperadrenocorticism with 1-deprenyl (Anipryl). Vet Clin North Am: Small Anim Pract 1997;27:273-286.
7. Reusch CE, Steffen T, Hoerauf A. The efficacy of L-Deprenyl in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1999;13:291-301.
8. Perez AM, Guerrero B, Melian C, Ynaraja E, Pena L. Use of aminoglutethimide in the treatment of pituitary-dependent hyperadrenocorticism in the dog. J Small Anim Pract 2002;43:104-108.
9. Feldman EC, Bruyette DS, Nelson RW, Farver TB. Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism. J Am Vet Med Assoc 1990;197:71-78.
10. Potts GO, Creange JE, Hardomg HR, Schane HP. Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids 1978;32:257-267.
11. Dewis P, Anderson DC, Bu'lock DE, Earnshaw R, Kelly WF. Experience with trilostane in the treatment of Cushing's syndrome. Clin Endocrinol (Oxf) 1983;18:533-540.
12. Semple CG, Beastall GH, Gray CE, Thomson JA. Trilostane in the management of Cushing's syndrome. Acta Endocrinol (Copenh) 1983;102:107-110.
13. Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002;63:506-512.
14. Grooters AM, Biller DS, Theisen SK, Miyabayashi T. Ultrasonographic characteristics of the adrenal glands in dogs with pituitary-dependent hyperadrenocorticism: comparison with normal dogs. J Vet Intern Med 1996;10:110-115.
15. Barthez PY, Nyland TG, Feldman EC. Ultrasonographic evaluation of the adrenal glands in dogs. J Am Vet Med Assoc 1995;207:1180-1183.
16. Barthez PY, Nyland TG, Feldman EC. Ultrasonography of the adrenal glands in the dog, cat, and ferret. Vet Clin North Am: Small Anim Pract 1998;28:869-885.
17. Gould SM, Baines EA, Mannion PA, Evans H, Herrtage ME. Use of endogenous ACTH concentration and adrenal ultrasonography to distinguish the cause of canine hyperadrenocorticism. J Small Anim Pract 2001;42:113-121.
18. Voorhout G, Stolp R, Lubberink AA, van Waes PF. Computed tomography in the diagnosis of canine hyperadrenocorticism not suppressible by dexamethasone. J Am Vet Med Assoc 1988;920:641-646.
19. Hoerauf A, Reusch C. Effects of mitotane therapy in dogs with pituitary dependent Cushing syndrome on the adrenal size - an ultrasonographic study. Schweiz Arch Tierheilkd 1999;141:239-245.
20. Torrance AG, Mooney CT. Reference ranges and test protocols. In: Torrance AG, Mooney CT (eds): Manual of small animal endocrinology. Cheltenham: BSAVA; 1998, pp 241-245.
21. Neiger R, Witt A. Effect of trilostane therapy on endogenous ACTH in 13 dogs with pituitary dependent hyperadrenocorticism. J Vet Intern Med 2002;16:632.
22. Neiger R, Campbell E. 24-hour cortisol values after trilostane therapy in dogs with hyperadrenocorticism. Proceedings of European Society of Veterinary Internal Medicine Congress. Neuchatelle, Switzerland; 2001, pp 31-32.
23. Lambert F, Corcelle-Cerf F, Lammerant J, Kolanowski J. On the specificity of the inhibitory effect of trilostane and aminoglutethimide on adrenocortical steroidogenesis in guinea pig. Mol Cell Endocrinol 1984;37:115-120.